The effect of solar-simulated radiation on the elicitation phase of contact hypersensitivity does not differ between controls and patients with polymorphic light eruption.
It has been suggested that polymorphic light eruption (PLE) is characterized by a failure of ultraviolet radiation (UVR)-induced immunosuppression, resulting in a type-IV hypersensitivity response to photoinduced antigens. We measured the effect of solar-simulated radiation (SSR) on the elicitation phase of contact hypersensitivity to 2,4-dinitrochlorobenzene (DNCB), in ten PLE patients and 11 controls. Subjects were given a sensitizing dose of DNCB, and 3 wk later were exposed to 0.75 and 2 minimum erythema doses (MED) of SSR on the upper inner arm. Immediately and 24 h later these sites, and a non-irradiated control site, were challenged with DNCB. The resulting increase in skin thickness was measured with high-frequency ultrasound. Overall, 2 MED caused 17%-20% suppression of elicitation responses (compared with 93% suppression of sensitization reported previously), but the effect of SSR varied greatly between subjects, with some subjects showing potentiated responses, which may be of relevance to false-positive reactions in photopatch testing. In a repeated measures general linear model, SSR overall caused significant suppression of responses (p<0.001); there was less suppression in older subjects (p=0.009) but there was no significant difference between PLE patients and age-matched normal controls. These results contrast with our previous finding of a resistance to UVR-induced suppression of sensitization to DNCB in PLE. This difference may reflect the greater importance of Langerhans cells in the sensitization phase, and is consistent with the hypothesis that PLE arises from impaired suppression of Langerhans cell activation or migration.
Palmer
Roy A
RA
Photobiology Unit, St John's Institute of Dermatology, Division of Skin Sciences, King's College London, London, UK. roypalmer@totalise.co.uk
Hawk
John L M
JL
Young
Anthony R
AR
Walker
Sue L
SL
D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D003877:Dermatitis, Contact / Q000150:complications* / Q000209:etiology*; D017454:Dermatitis, Photoallergic / Q000150:complications*; D004137:Dinitrochlorobenzene; D006801:Humans; D007509:Irritants; D008875:Middle Aged; D013472:Sunlight
D004137:Dinitrochlorobenzene; D007509:Irritants